Skip to main content
Livermore
Livermore
ZHEN

Overbrook Management Corp

SEC CIK
0001269786
Latest filing
Jul 30, 2026

CLDX holding history

Celldex Therapeutics, Inc. in every 13F filed by Overbrook Management Corp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CLDX overviewAll 13F holders of CLDXFull Q2 2026 holdings

Shares (Q2 2026)
11,537
Value
$429.3K
% of portfolio
0.1%
Quarters held
15
Since Q1 2022
Holdings of CLDX by Overbrook Management Corp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202611,537$429.3K0.1%00.0%UnchangedHolders
Q1 202611,537$366.0K0.1%00.0%UnchangedHolders
Q4 202511,537$313.3K0.1%+2,740+31.1%AddedHolders
Q3 20258,797$227.6K<0.1%+8,797NewHolders
Q4 20240$00.0%−6,837−100.0%Sold outHolders
Q3 20246,837$232.4K0.1%00.0%UnchangedHolders
Q2 20246,837$253.0K0.1%−252−3.6%ReducedHolders
Q1 20247,089$297.5K0.1%−555−7.3%ReducedHolders
Q4 20237,644$303.2K0.1%00.0%UnchangedHolders
Q3 20237,644$210.4K<0.1%−119−1.5%ReducedHolders
Q2 20237,763$263.4K0.1%00.0%UnchangedHolders
Q1 20237,763$279.3K0.1%−312−3.9%ReducedHolders
Q4 20228,075$359.9K0.1%00.0%UnchangedHolders
Q3 20228,075$227.0K0.1%−165−2.0%ReducedHolders
Q2 20228,240$222.0K0.1%00.0%UnchangedHolders
Q1 20228,240$281.0K0.1%+8,240NewHolders